RICHARD A LAWHERN; PAT IRVING RN. The FDA is Talking When They Should Be Listening – Part 2: Review Article. American Journal of Medical and Clinical Research & Reviews, [S. l.], v. 4, n. 9, p. 1–3, 2025. DOI: 10.58372/2835-6276.1333. Disponível em: https://ajmcrr.com/index.php/pub/article/view/347. Acesso em: 7 sep. 2025.